Nitric oxide and endothelins are effector agents of hyperacute vascular rejection.
Castillo
J
J
Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Berrazueta
J R
JR
Herrera
L
L
de Vega
M J
MJ
Val
J F
JF
Amado
J A
JA
Gómez
J
J
Gómez-Fleitas
M
M
D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D004285:Dogs; D004533:Egtazic Acid / Q000494:pharmacology; D016232:Endothelins / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006084:Graft Rejection / Q000276:immunology / Q000503:physiopathology*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D012079:Renal Circulation; D013552:Swine; D014182:Transplantation, Autologous / Q000276:immunology / Q000502:physiology; D014183:Transplantation, Heterologous / Q000276:immunology / Q000502:physiology*; D019323:omega-N-Methylarginine
D016232:Endothelins; D004791:Enzyme Inhibitors; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D004533:Egtazic Acid; D001120:Arginine; D019001:Nitric Oxide Synthase